Testing a Novel Therapeutic Approach in Two Rat Models with GA Features

Time: 2:45 pm
day: Track 1 Day 1 PM 1


  • Describe two different rat models for dry AMD, an acute subretinal NaIO3 model, and our 48/80 model driven by mast cell degranulation
  • Describe Stuart Therapeutics novel treatment compounds and why these models are an ideal  modality to test efficacy and mode of action
  • Investigate how intravitreal injection of PolyColTM peptides affects disease pathology in rat GA model (s)